Thomas Morel
Impact in
- Neurology top 10%
- Parkinson's Disease Mechanisms and Treatments
- Neurological disorders and treatments
- Myasthenia Gravis and Thymoma
- Economics and Econometrics top 5%
- Health Systems, Economic Evaluations, Quality of Life
- Pharmaceutical Economics and Policy
Papers in
- Neurology 10
- Parkinson's Disease Mechanisms and Treatments 7
- Myasthenia Gravis and Thymoma 3
- Neurological disorders and treatments 2
-
- Health Systems, Economic Evaluations, Quality of Life 8
- Pharmaceutical Economics and Policy 3
- Co-authors
- Stefan Cano (10 shared papers)Steven Simoens (8 shared papers)Antoine Regnault (7 shared papers)Babak Boroojerdi (4 shared papers)Juliette Meunier (1 shared paper)Massimo Bani (1 shared paper)David Cassiman (3 shared papers)P.D. Siviero (2 shared papers)
- Journals
- Orphanet Journal of Rare Diseases (6 papers)Nature Reviews Drug Discovery (3 papers)Value in Health (2 papers)Rheumatology and Therapy (2 papers)Journal of Palliative Medicine (2 papers)
- Partner nations
- BelgiumUnited StatesUnited Kingdom
In The Last Decade
Thomas Morel
31 papers receiving 653 citations
Peers
Comparison fields: 5 of 73
- Neurology 152
- Economics and Econometrics 183
- Genetics 25
- Physical Therapy, Sports Therapy and Rehabilitation 10
- Genetics 64
Countries citing papers authored by Thomas Morel
This map shows the geographic impact of Thomas Morel's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Thomas Morel with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Thomas Morel more than expected).
Fields of papers citing papers by Thomas Morel
This network shows the impact of papers produced by Thomas Morel. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Thomas Morel. The network helps show where Thomas Morel may publish in the future.
Co-authors
The 25 scholars most cited alongside Thomas Morel, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 33 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2019 | 131 | |
| 2 | 2017 | 116 | |
| 3 | 2013 | 94 | |
| 4 | 2018 | 90 | |
| 5 | 2014 | 39 | |
| 6 | 2016 | 37 | |
| 7 | 2022 | 17 | |
| 8 | 2023 | 15 | |
| 9 | 2021 | 13 | |
| 10 | 2016 | 12 | |
| 11 | 2014 | 12 | |
| 12 | 2014 | 9 | |
| 13 | 2022 | 9 | |
| 14 | 2021 | 9 | |
| 15 | 2023 | 9 | |
| 16 | 2013 | 8 | |
| 17 | 2021 | 8 | |
| 18 | 2017 | 7 | |
| 19 | 2014 | 7 | |
| 20 | 2023 | 5 |
About Thomas Morel
Thomas Morel is a scholar working on Neurology, Economics and Econometrics, Genetics, Rheumatology and Public Health, Environmental and Occupational Health, having authored 33 papers that have together received 670 indexed citations. Recurring topics across this work include Health Systems, Economic Evaluations, Quality of Life (8 papers), Parkinson's Disease Mechanisms and Treatments (7 papers), Genomics and Rare Diseases (4 papers), Systemic Lupus Erythematosus Research (4 papers), Biotechnology and Related Fields (3 papers), Pharmaceutical Economics and Policy (3 papers), Myasthenia Gravis and Thymoma (3 papers) and Neurological disorders and treatments (2 papers). The work is most often cited by research in Neurology (152 citations), Economics and Econometrics (183 citations), Genetics (25 citations), Physical Therapy, Sports Therapy and Rehabilitation (10 citations) and Genetics (64 citations). Thomas Morel has collaborated with scholars based in Belgium, United States and United Kingdom. Frequent co-authors include Stefan Cano, Steven Simoens, Antoine Regnault, Babak Boroojerdi, Juliette Meunier, Massimo Bani, David Cassiman, P.D. Siviero, Francis Arickx and Entela Xoxi. Their work appears in journals such as Orphanet Journal of Rare Diseases, Nature Reviews Drug Discovery, Value in Health, Rheumatology and Therapy and Journal of Palliative Medicine.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.